• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Exclusive: Moichor opens preorders for image-based CBC point-of-care device

April 18, 2022
dvm360 Staff

According to Moichor, the AI-powered CBC device will make it possible to receive a STAT pathology review within 2 hours of running the slide through the device

Moichor, an AI-powered animal diagnostic company, announced today it will open preorders for its image-based, point-of-care, complete blood count (CBC) device. According to a press release from Moichor, this device is the first of its kind in the veterinary space, and the inspiration behind the company’s technology is the desire to make pathology-level insights the standard of veterinary health rather than a diagnostic only for the sickest patients.1

The company’s CEO, Shevy Karbassi, says the device’s value comes from what happens when Moichor’s software parses and organizes the images of cells. “The device makes high-throughput image-based CBCs possible in a way that can sort, share, and analyze pathology objects,” Moichor CEO Shevy Karbasi said. “That means a slide of any species can be run anywhere in the world and our computer vision software will immediately be able to count and organize these objects,” he said.1

“If the Artificial Intelligence (AI) sees a particular set of objects, or perhaps a species that needs more training data, the sample is flagged for a pathologist review and the AI organizes the objects for the pathologist,” he added.

Kaori Davis DVM, PhD, DACVP (Clinical Pathology), director of pathology at Moichor, said the sorting makes it possible to achieve a higher level of accuracy and less variability. “The AI sorting allows us to review large numbers of cells in a shorter amount of time, and it also lets us compare the morphology of the same cells side-by-side, which cannot be done with traditional microscopy,” she said.

According to Karbasi, the company’s pathologist-trained computer vision algorithm consists of more than 2 million pathology objects from over 350 different species—not just mammals.1

Advertisement

“With Moichor, all CBCs come with a complementary pathology review and this device will make it possible to get a STAT pathology review in under 2 hours from running the slide through the device,” Karbasi said.

One of the biggest advantages, according to Davis, is that everyone is looking at the same images. “When the device scans a slide and organizes the pathology objects, both the clinician and my team are all looking at the same cells. We can show what we’re looking at and how that impacts our interpretation,” Davis said. “That wasn’t previously possible.”

With the software having now viewed over 2 million pathology objects, Moichor released 36 new reference intervals. Karbasi said Moichor is currently putting devices in select clinics throughout the US to refine the hardware but anticipates the first commercially available devices to begin shipping to customers in September 2022. In the meantime, Moichor continues to offer complimentary pathology for all hematology.

Reference

Moichor opens preorders for image-based CBC point-of-care device. News release. Moichor. April 18, 2022.

Related Content:

ProductsMedicalImaging
Details of new pet performance supplement line revealed
Details of new pet performance supplement line revealed
Drug for acute onset of canine pancreatitis is launched on the US market
Drug for acute onset of canine pancreatitis is launched on the US market
New Automatic 2-in-1 Pet Feeder and Water Dispenser launched
New Automatic 2-in-1 Pet Feeder and Water Dispenser launched

Advertisement

Latest News

Four ways to curb no shows

FDA and European Union expand Mutual Recognition Agreement to include animal drugs

Successful tolerability study of CBD products for dogs

Second annual 'Dog Days of Summer' adoption event to take place in Michigan

View More Latest News
Advertisement